Amphivena Therapeutics, Inc.
3 clinical trials · Sponsor
◉ Watch Amphivena Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Study of AMV564 in Subjects With Advanced Solid Tumors (NCT04128423) | Amphivena Therapeutics, Inc. | 2019-10-09 |
| A Phase 1 Study of AMV564 in Patients With Intermediate or High-Risk Myelodysplastic Syndromes (NCT03516591) | Amphivena Therapeutics, Inc. | 2018-06-22 |
Track Amphivena Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.